The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy

L. C. Hanker, S. Loibl, N. Burchardi, J. Pfisterer, W. Meier, E. Pujade-Lauraine, I. Ray-Coquard, J. Sehouli, P. Harter, A. du bois

    Fingerprint

    Dive into the research topics of 'The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy'. Together they form a unique fingerprint.

    Medicine & Life Sciences